Anti-renal fibrosis natural product Commiphorane C isomer as well as preparation method and application thereof

The invention discloses an anti-renal fibrosis natural product Commiphorane C isomer as well as a preparation method, a pharmaceutical composition and application thereof, and belongs to the technical field of medicines. The invention specifically relates to compounds represented by formulas Ia, Ib, Ic and Id or isomers and pharmaceutically acceptable salts thereof, and a preparation method thereof. A new pharmaceutical composition comprises effective doses of compounds of formulae Ia, Ib, Ic and Id and a pharmacodynamically acceptable carrier. The invention also discloses application of the compound in prevention and/or treatment of renal fibrosis and/or chronic renal failure caused by renal fibrosis..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 30. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

XIE PING [VerfasserIn]
JIAO XIAOZHEN [VerfasserIn]
LIU XIAOYU [VerfasserIn]
JIANG YINGJUN [VerfasserIn]
WANG ZHENWEI [VerfasserIn]
WU YUANYUAN [VerfasserIn]
CAO YANG [VerfasserIn]
WANG ZHE [VerfasserIn]
LI WENXUAN [VerfasserIn]
WANG YUAN [VerfasserIn]
MA BO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07D: Heterocyclic compounds (macromolecular compounds c0 (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-06-30, Last update posted on www.tib.eu: 2023-11-28, Last updated: 2023-12-01

Patentnummer:

CN116354913

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA018100406